GlobeNewswire
Passage Bio to Participate in Upcoming Investor Conferences
📊
AI Sentiment
Positive
6/10
- Home
- PASG
PASG
Passage Bio Inc.
as of 02-24-2026 9:33am EST
$9.35
+$0.62
+7.10%
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
| Founded: | 2017 | Country: | United States |
| Employees: | 27 | City: | PHILADELPHIA |
| Market Cap: | 28.3M | IPO Year: | 2020 |
| Target Price: | $34.50 | AVG Volume (30 days): | 31.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.26 | EPS Growth: | 42.47 |
| 52 Week Low/High: | $0.28 - $20.00 | Next Earning Date: | 04-06-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.86 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Passage Bio Inc. (PASG)
Sell
PASG Jan 8, 2026
Avg Cost/Share
$18.44
Shares
2,062
Total Value
$38,022.04
Owned After
5,402
SEC Form 4
Chou William
Sell
PRESIDENT AND CEO
PASG Jan 8, 2026
Avg Cost/Share
$18.44
Shares
4,076
Total Value
$75,158.99
Owned After
6,524
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Borthwick Kathleen | PASG | CFO | Jan 8, 2026 | Sell | $18.44 | 2,062 | $38,022.04 | 5,402 | |
| Chou William | PASG | PRESIDENT AND CEO | Jan 8, 2026 | Sell | $18.44 | 4,076 | $75,158.99 | 6,524 |
Latest Passage Bio Inc. News
PASG Breaking Stock News: Dive into PASG Ticker-Specific Updates for Smart Investing
Compare PASG vs Leading Stocks
See how PASG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PASG Passage Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.